Last Updated: 11/06/2014 23:27:21
TRX Stock Chart - 1 Month
TRX Stock Chart - 3 Month
TRX Stock Chart - 6 Month
TRX Stock Chart - 1 Year
TRX Stock Chart - 2 Year
Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...
Continue Reading
They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...
Continue Reading
Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...
Continue Reading
CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...
Continue Reading
If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
First Savings Financial Group, Inc. Declares Special Cash Dividend In a recent announcement, First Savings Financial Group, Inc. (NASDAQ: FSFG), a prominent holding company, revealed that their Board of Directors has approved a quarterly cash dividend of $0.16 per common share. This generous dividend is a reflection of the company’s positive financial health and...
Continue Reading
Ransomware Attacks Surge: Insights from Coalition's Findings SAN FRANCISCO-- Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, has published its latest findings revealing a significant turnaround in the landscape of cyber threats. Recent statistics show that ransomware claims severity has increased by 68%, reaching...
Continue Reading
On February 17, 2026, Metropolitan Commercial Bank (MCB) completed a major transition by fully retiring its legacy ACH mainframe and moving to Finzly’s cloud-native payment platform. This move positions MCB as a pioneer among U. S. banks as the industry grapples with modernizing aging systems—a reality that has been highlighted by looming regulatory changes. You know...
Continue Reading
GEODIS Appoints New President and CEO for the Americas GEODIS, a prominent figure in the logistics and transportation industry, has announced the appointment of Laura Ritchey to the position of President & CEO of its Americas region. In this crucial role, Ritchey will be part of the Group's Executive Board and will report to Marie-Christine Lombard, the Group's Chief...
Continue Reading
Conagra Brands Announces Earnings Release Date Conagra Brands, Inc. (NYSE: CAG) recently made a significant announcement regarding its fiscal 2026 second quarter results. The much-anticipated earnings release is scheduled for a Friday, marking an important milestone for the company and its stakeholders. Details of the Earnings Call The earnings call will take place on a...
Continue Reading